EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Beyond the Treatment Peak: Why We Need Pharmacotherapeutic Follow-Up Protocols for the Withdrawal of Metabolic Weight-Loss Therapies

João Pedro Ferreira Drumond

Diabetes & Obesity International Journal · 17.11.2026 · 11 (2) · 1-5

DOI: 10.23880/doij-16000302 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes & Obesity International Journal, online erschienen am 17.11.2026. Verfasst von João Pedro Ferreira Drumond. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The advent of next-generation incretin therapies has revolutionized the management of obesity and cardiometabolic diseases, achieving significant and historically unprecedented weight reductions in pharmacotherapy. However, the commercial appeal and aesthetic pressure from social media have transformed these medications into short-term body remodeling tools, creating a false perception of a "definitive solution" and diverting attention from the need for long-term management. This opinion article examines the global impact of these therapies and critiques the lack of clinical guidelines addressing the post-achievement phase of therapeutic goals. Abrupt discontinuation or loss of follow-up triggers compensatory neuroendocrine adaptations, resulting in weight cycling and the development of sarcopenic obesity due to disproportionate regain of visceral fat. It is concluded that obesity management should not stop at the peak phase of treatment. The implementation of structured deprescribing protocols (gradual tapering) co-managed by the endocrinologist and the clinical pharmacist, integrated into the interdisciplinary team, is advocated, transforming discontinuation into an active and safe step for the continuous maintenance of cardiometabolic health.

Zitieren

APA

Drumond, J. P. F. (2026). Beyond the Treatment Peak: Why We Need Pharmacotherapeutic Follow-Up Protocols for the Withdrawal of Metabolic Weight-Loss Therapies. Diabetes & Obesity International Journal, 11(2), 1-5. https://doi.org/10.23880/doij-16000302

Vancouver

Drumond JPF. Beyond the Treatment Peak: Why We Need Pharmacotherapeutic Follow-Up Protocols for the Withdrawal of Metabolic Weight-Loss Therapies. Diabetes & Obesity International Journal. 2026;11(2):1-5. doi:10.23880/doij-16000302

BibTeX
@article{Drumond2026,
  author = {Drumond, João Pedro Ferreira},
  title = {Beyond the Treatment Peak: Why We Need Pharmacotherapeutic Follow-Up Protocols for the Withdrawal of Metabolic Weight-Loss Therapies},
  journal = {Diabetes & Obesity International Journal},
  year = {2026},
  volume = {11},
  number = {2},
  pages = {1--5},
  doi = {10.23880/doij-16000302}
}
Kostenlos starten →